“…With more than half the world under lock-down in order to contain the spread of this pandemic, with no immediate vaccine available, it has become the need of the hour to develop rapid detection methods to diagnose nCovid-19 in both symptomatic as well as asymptomatic patients (Mizumoto et al, 2020) that would enable early mitigation. For early diagnosis, chest computed tomography (CT) (Bai et al, 2020;Bernheim et al, 2020;Li and Xia, 2020;Pan et al, 2020a) was used whereas in the analytical stage, realtime reverse-transcriptase polymerase chain reaction (RT-PCR) Corman et al, 2020;Lan et al, 2020;Loeffelholz and Tang, 2020) remains the standard test for the etiologic diagnosis of SARS-CoV-2 (Ai et al, 2020;Fang et al, 2020). Recently, antibody and CRISPR based techniques are being introduced as supplemental tools for rapid diagnosis Ding et al, 2020;Yang et al, 2020).…”